This inventor holds 1 USPTO granted patent. Top assignee: Biogal Gyogyszergyar Rt.. Active years: 1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996
Title: J Anos Erdei: Innovator in Recombinant Biotechnology
Introduction
J Anos Erdei is a notable inventor based in Debrecen, Hungary. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant proteins. His work has implications for medical advancements, especially in blood coagulation therapies.
Latest Patents
Erdei holds a patent for "Plasmids and process for producing recombinant desulphatohirudin HV-1." This invention relates to a process for producing recombinant desulphatohirudin by culturing microorganisms. The synthesized nucleotide sequences were strategically joined downstream of isolated promoters and signal sequences. The expression/secretion cassettes were then inserted into plasmid DNAs, allowing for the cultivation of cells under selective culture conditions. E. coli, Saccharomyces, and Streptomyces species were transformed with these recombinant plasmids to biosynthesize the thrombin inhibitor desulphatohirudin HV-1, which was subsequently isolated and identified. The desulphatohirudin produced can be utilized to inhibit blood coagulation.
Career Highlights
Erdei is associated with Biogal Gyogyszergyar Rt., a company that focuses on pharmaceutical development. His innovative work in recombinant biotechnology has positioned him as a key figure in the industry. He has successfully navigated the complexities of genetic engineering to create valuable medical products.
Collaborations
Erdei has collaborated with notable colleagues, including Erika Zilahi and István Barta. These partnerships have enhanced his research and development efforts, contributing to the success of his projects.
Conclusion
J Anos Erdei's contributions to recombinant biotechnology exemplify the impact of innovation in medicine. His work not only advances scientific knowledge but also holds promise for future therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile